Publications

4536 Results

L-sarcolysin (NSC-8806) therapy for acute leukemia in children

Authors
TM Holcomb;DH Berry;ME Haggard;MP Sullivan;WL Watkins;J Windmiller
Journal / Conference
Cancer Chemo- therapy Reports 48:45-48
Year
1965
Research Committee(s)
Leukemia

The response of acute childhood leukemia to an initial and second course of prednisone.

Authors
TJ Vietti;MP Sullivan;DH Berry;TB Haddy;ME Haggard;RJ Blattner
Journal / Conference
J Pediatrics 66(1):18-26
Year
1965
Research Committee(s)
Leukemia

L-phenylalanine mustard (NSC-8806) in uncommon malignant disease in children.

Authors
MP Sullivan;DJ Fernbach;ME Haggard;TM Holcomb;J Lusher
Journal / Conference
Cancer Chemo- therapy Reports 45:63-67
Year
1965

Phase II studies of hydroxyurea (NSC-32065) in adults: Cancer of the breast

Authors
ME Sears
Journal / Conference
Cancer Chemotherapy Reports 40:43
Year
1964
Research Committee(s)
Breast

Renal abnormalities induced by hydroxyurea (NSC-32065).

Authors
ML Samuels;CD Howe
Journal / Conference
Cancer Chemotherapy Reports 40:9-13
Year
1964
Research Committee(s)
Gastrointestinal

Phase II studies of hydroxyurea (NSC-32065) in adults: Urologic and gynecologic neoplasms.

Authors
CD Howe;ML Samuels
Journal / Conference
Cancer Chemotherapy Reports 40:47-48
Year
1964
Research Committee(s)
Genitourinary and Gynecologic

Antileukemic activity of hydroxyurea (NSC-32065) and other urea derivatives

Authors
A Goldin;JM Venditti;JAR Mead;JP Glynn
Journal / Conference
Cancer Chemotherapy Reports 40:57-74
Year
1964
Research Committee(s)
Leukemia

Phase II studies of hydroxyurea (NSC-32065) in adults: Leukemia

Authors
CC Shullenberger
Journal / Conference
Cancer Chemotherapy Reports 40:49-50
Year
1964
Research Committee(s)
Leukemia

Phase II studies of hydroxyurea (NSC-32065) in adults: Carcinoma of the lung.

Authors
JN Bickers
Journal / Conference
Cancer Chemotherapy Reports 40:45-46
Year
1964
Research Committee(s)
Lung

Phase II studies of hydroxyurea (NSC-32065) in adults: Multiple myeloma and lymphoma.

Authors
P Davis
Journal / Conference
Cancer Chemotherapy Reports 40:51-52
Year
1964
Research Committee(s)
Lymphoma and Myeloma